GuruFocus · AIS · October 26, 2026

Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization

Get the app for more

Explore stock news, insights and company research.